Vicus Capital Sells 1,460 Shares of UnitedHealth Group Incorporated (NYSE:UNH)

Vicus Capital lowered its holdings in UnitedHealth Group Incorporated (NYSE:UNH) by 75.3% in the fourth quarter, according to its most recent 13F filing with the Securities & Exchange Commission. The firm owned 479 shares of the healthcare conglomerate’s stock after selling 1,460 shares during the period. Vicus Capital’s holdings in UnitedHealth Group were worth $252,000 at the end of the most recent quarter.

A number of other institutional investors have also recently bought and sold shares of UNH. Moneta Group Investment Advisors LLC lifted its holdings in shares of UnitedHealth Group by 100,076.4% during the 4th quarter. Moneta Group Investment Advisors LLC now owns 11,823,820 shares of the healthcare conglomerate’s stock worth $6,268,753,000 after acquiring an additional 11,812,017 shares during the period. Norges Bank bought a new stake in shares of UnitedHealth Group during the 4th quarter worth approximately $5,210,004,000. Arrowstreet Capital Limited Partnership lifted its holdings in shares of UnitedHealth Group by 1,682.4% during the 1st quarter. Arrowstreet Capital Limited Partnership now owns 2,691,542 shares of the healthcare conglomerate’s stock worth $1,372,606,000 after acquiring an additional 2,540,538 shares during the period. International Assets Investment Management LLC lifted its holdings in shares of UnitedHealth Group by 53,573.1% during the 4th quarter. International Assets Investment Management LLC now owns 2,352,490 shares of the healthcare conglomerate’s stock worth $1,238,515,000 after acquiring an additional 2,348,107 shares during the period. Finally, Barclays PLC lifted its holdings in shares of UnitedHealth Group by 143.4% during the 2nd quarter. Barclays PLC now owns 3,494,100 shares of the healthcare conglomerate’s stock worth $1,679,401,000 after acquiring an additional 2,058,829 shares during the period. Institutional investors own 87.86% of the company’s stock.

UnitedHealth Group Trading Up 1.6 %

UNH opened at $501.13 on Monday. UnitedHealth Group Incorporated has a twelve month low of $436.38 and a twelve month high of $554.70. The company has a quick ratio of 0.79, a current ratio of 0.85 and a debt-to-equity ratio of 0.69. The company has a fifty day moving average of $488.63 and a 200-day moving average of $515.20. The stock has a market cap of $462.01 billion, a PE ratio of 30.63, a price-to-earnings-growth ratio of 1.38 and a beta of 0.54.

UnitedHealth Group (NYSE:UNH) last posted its quarterly earnings results on Tuesday, April 16th. The healthcare conglomerate reported $6.91 EPS for the quarter, topping analysts’ consensus estimates of $6.63 by $0.28. The business had revenue of $99.80 billion during the quarter, compared to analysts’ expectations of $99.23 billion. UnitedHealth Group had a net margin of 4.05% and a return on equity of 26.50%. The business’s quarterly revenue was up 8.6% on a year-over-year basis. During the same period last year, the company posted $6.26 earnings per share. On average, sell-side analysts predict that UnitedHealth Group Incorporated will post 27.61 EPS for the current year.

UnitedHealth Group Dividend Announcement

The business also recently declared a quarterly dividend, which was paid on Tuesday, March 19th. Shareholders of record on Monday, March 11th were issued a $1.88 dividend. This represents a $7.52 dividend on an annualized basis and a yield of 1.50%. The ex-dividend date was Friday, March 8th. UnitedHealth Group’s payout ratio is 45.97%.

Insiders Place Their Bets

In other UnitedHealth Group news, CAO Thomas E. Roos sold 858 shares of the firm’s stock in a transaction on Friday, February 23rd. The shares were sold at an average price of $525.79, for a total value of $451,127.82. Following the transaction, the chief accounting officer now directly owns 32,289 shares of the company’s stock, valued at $16,977,233.31. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through this link. In other UnitedHealth Group news, EVP Erin Mcsweeney sold 1,236 shares of the firm’s stock in a transaction on Friday, March 8th. The shares were sold at an average price of $483.48, for a total value of $597,581.28. Following the transaction, the executive vice president now directly owns 9,364 shares of the company’s stock, valued at $4,527,306.72. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through this link. Also, CAO Thomas E. Roos sold 858 shares of the firm’s stock in a transaction dated Friday, February 23rd. The shares were sold at an average price of $525.79, for a total transaction of $451,127.82. Following the transaction, the chief accounting officer now directly owns 32,289 shares in the company, valued at $16,977,233.31. The disclosure for this sale can be found here. Corporate insiders own 0.35% of the company’s stock.

Analyst Ratings Changes

Several equities analysts recently commented on the stock. Wells Fargo & Company dropped their price objective on shares of UnitedHealth Group from $600.00 to $525.00 and set an “overweight” rating for the company in a research note on Monday, April 8th. Stephens reissued an “overweight” rating and issued a $605.00 price objective on shares of UnitedHealth Group in a research note on Thursday, February 8th. Piper Sandler increased their price objective on shares of UnitedHealth Group from $566.00 to $571.00 and gave the company an “overweight” rating in a research note on Wednesday, April 17th. Erste Group Bank reissued a “hold” rating on shares of UnitedHealth Group in a research note on Wednesday, March 13th. Finally, Deutsche Bank Aktiengesellschaft upped their price target on shares of UnitedHealth Group from $545.00 to $562.00 and gave the company a “buy” rating in a research report on Friday. Four investment analysts have rated the stock with a hold rating and fifteen have assigned a buy rating to the company’s stock. According to MarketBeat.com, the stock has an average rating of “Moderate Buy” and a consensus target price of $570.05.

About UnitedHealth Group

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.